ImClone (IMCL) January derivative prices Elevated into positive Phase 3 trial results for colorectal cancer
Tweet Send to a Friend
ImClone (Nasdaq: IMCL) : IMCL is recently up $2.03 to $31.25 in pre-opening ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
